Peddock Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,175
Closed -$205K 159
2021
Q4
$205K Buy
+1,175
New +$196K 0.07% 141
2021
Q3
Sell
-1,175
Closed -$213K 143
2021
Q2
$213K Hold
1,175
0.07% 139
2021
Q1
$227K Hold
1,175
0.09% 133
2020
Q4
$237K Hold
1,175
0.12% 101
2020
Q3
$247K Sell
1,175
-110
-9% -$24.5K 0.15% 95
2020
Q2
$282K Hold
1,285
0.18% 86
2020
Q1
$223K Sell
1,285
-315
-20% -$52K 0.17% 91
2019
Q4
$246K Hold
1,600
0.13% 100
2019
Q3
$243K Hold
1,600
0.13% 102
2019
Q2
$245K Hold
1,600
0.13% 101
2019
Q1
$257K Hold
1,600
0.14% 94
2018
Q4
$247K Hold
1,600
0.15% 93
2018
Q3
$241K Hold
1,600
0.12% 108
2018
Q2
$216K Hold
1,600
0.11% 112
2018
Q1
$213K Hold
1,600
0.11% 112
2017
Q4
$238K Hold
1,600
0.12% 110
2017
Q3
$211K Hold
1,600
0.11% 112
2017
Q2
$213K Hold
1,600
0.11% 109
2017
Q1
$216K Hold
1,600
0.12% 100
2016
Q4
$192K Hold
1,600
0.11% 100
2016
Q3
$200K Hold
1,600
0.12% 95
2016
Q2
$221K Hold
1,600
0.14% 88
2016
Q1
$202K Hold
1,600
0.15% 87
2015
Q4
$203K Buy
+1,600
New +$199K 0.16% 90

Other funds holding CLX

Peddock Capital Advisors's CLX Position: Q1 2022 in Review

Peddock Capital Advisors sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,175 shares — an estimated $205K sold.

Peddock Capital Advisors first reported a position in CLX in Q4 2015 and held it in 24 quarters. The position peaked at $282K in Q2 2020. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • Peddock Capital Advisors reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
  • Peddock Capital Advisors sold 1,175 Clorox shares in Q1 2022, an estimated $205K.
  • Peddock Capital Advisors first reported a position in Clorox in Q4 2015 and held it in 24 quarters.
  • Peddock Capital Advisors's Clorox position peaked at $282K in Q2 2020.
  • 1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Peddock Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.